Erstellt am 2021/02/19, Последнее изменение: 2021/02/19 https://kinderkrebsinfo.de/doi/e8952

Autor(en) Titel Quelle Links
Aarbakke J, Janka-Schaub G, Elion G Thiopurine biology and pharmacology. Trends Pharmacol Sci 1997, 18: 3    
Abdollahzadeh M, Hoffman HJ, Blazer SI, Becker LE, Humphreys RP, Drake JM, Rutka JT Benign cerebellar astrocytoma in childhood: experience at the Hospital for Sick Children 1980-1992. Childs Nerv Syst 1994, 10: 380    
Abele M, Voggel S, Bremensdorfer C, Spix C, Erdmann F, Kuhlen M, Redlich A, Ebinger M, Lang P, Schneider DT, Brecht IB Incidences and characteristics of primary lung malignancies in childhood in Germany: An analysis of population-based data from German cancer registries. Pediatric blood & cancer 2022,e2974    
Abla O, Kutny MA, Testi AM, Feusner JH, Creutzig U, Gregory J Jr, Gibson B, Leverger G, Ribeiro RC, Smith O, Locatelli F, Kaspers G Management of relapsed and refractory childhood acute promyelocytic leukaemia: recommendations from an international expert panel. British journal of haematology 2016, 175: 588    
Abramson DH, Frank CM Second nonocular tumors in survivors of bilateral retinoblastoma: a possible age effect on radiation-related risk. Ophthalmology 1998, 105: 573-9; discussion 579    
Achajew A, Brecht IB, Radespiel-Tröger M, Meyer M, Metzler M, Bremensdorfer C, Spix C, Erdmann F, Schneider DT, Abele M Rare pediatric tumors in Germany - not as rare as expected: a study based on data from the Bavarian Cancer Registry and the German Childhood Cancer Registry. European journal of pediatrics 2022, 181: 2723    
Ackermann S, Cartolano M, Hero B, Welte A, Kahlert Y, Roderwieser A, Bartenhagen C, Walter E, Gecht J, Kerschke L, Volland R, Menon R, Heuckmann JM, Gartlgruber M, Hartlieb S, Henrich KO, Okonechnikov K, Altmüller J, Nürnberg P, Lefever S, de Wilde B, Sand F, Ikram F, Rosswog C, Fischer J, Theissen J, Hertwig F, Singhi AD, Simon T, Vogel W, Perner S, Krug B, Schmidt M, Rahmann S, Achter V, Lang U, Vokuhl C, Ortmann M, Büttner R, Eggert A, Speleman F, O'Sullivan RJ, Thomas RK, Berthold F, Vandesompele J, Schramm A, Westermann F, Schulte JH, Peifer M, Fischer M A mechanistic classification of clinical phenotypes in neuroblastoma. Science (New York, N.Y.) 2018 Dec 7; 362: 1165    
Adams RJ Prevention of stroke in sickle cell anemia. The Journal of law, medicine & ethics 2014, 42: 135    
Adams RJ, Cox M, Ozark SD, Kanter J, Schulte PJ, Xian Y, Fonarow GC, Smith EE, Schwamm LH Coexistent Sickle Cell Disease Has No Impact on the Safety or Outcome of Lytic Therapy in Acute Ischemic Stroke: Findings From Get With The Guidelines-Stroke. Stroke 2017, 48: 686    
Adolph JE, Fleischhack G, Mikasch R, Zeller J, Warmuth-Metz M, Bison B, Mynarek M, Rutkowski S, Schüller U, von Hoff K, Obrecht D, Pietsch T, Pfister SM, Pajtler KW, Witt O, Witt H, Kortmann RD, Timmermann B, Krauß J, Frühwald MC, Faldum A, Kwiecien R, Bode U, Tippelt S Local and systemic therapy of recurrent ependymoma in children and adolescents: short- and long-term results of the E-HIT-REZ 2005 study. Neuro-oncology 2021, 23: 1012    
Adolph JE, Fleischhack G, Gaab C, Mikasch R, Mynarek M, Rutkowski S, Schüller U, Pfister SM, Pajtler KW, Milde T, Witt O, Bison B, Warmuth-Metz M, Kortmann RD, Dietzsch S, Pietsch T, Timmermann B, Tippelt S, German GPOH HIT-Network Systemic chemotherapy of pediatric recurrent ependymomas: results from the German HIT-REZ studies. Journal of neuro-oncology 2021, 155: 193    
Aerts I, Sastre-Garau X, Savignoni A, Lumbroso-Le Rouic L, Thebaud-Leculée E, Frappaz D, Coze C, Thomas C, Gauthier-Villars M, L'evy-Gabriel C, Brisse HJ, Desjardins L, Doz F Results of a Multicenter Prospective Study on the Postoperative Treatment of Unilateral Retinoblastoma Following Primary Enucleation. J Clin Oncol 2013 Mar 4; [Epub ahead of print]    
Agostini A, Cicardi M Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients. Medicine 1992l; 71: 206-15.    
Agrawal AK, Hsu E, Quirolo K, Neumayr LD, Flori HR Red blood cell transfusion in pediatric patients with severe chronic anemia: How slow is necessary? Pediatric blood & cancer 2012, 58: 466    
Aguilar Martinez P, Angastiniotis M, Eleftheriou A, Gulbis B, Mañú Pereira Mdel M, Petrova-Benedict R, Corrons JL Haemoglobinopathies in Europe: health & migration policy perspectives. Orphanet journal of rare diseases 2014, 9: 97    
Ahrens S, Hoffmann C, Jabar S, Braun-Munzinger G, Paulussen M, Dunst J, Rübe C, Winkelmann W, Heinecke A, Göbel U, Winkler K, Harms D, Treuner J, Jürgens H Evaluation of prognostic factors in a tumor volume-adapted treatment strategy for localized Ewing sarcoma of bone. Med Pediatr Oncol 1999, 32: 186    
Aich A, Jones MK, Gupta K Pain and sickle cell disease. Current opinion in hematology 2019, 26: 131    
Ait-Tahar K, Damm-Welk C, Burkhardt B, Zimmermann M, Klapper W, Reiter A, Pulford K, Woessmann W Correlation of the autoantibody response to the ALK oncoantigen in pediatric anaplastic lymphoma kinase-positive anaplastic large cell lymphoma with tumor dissemination and relapse risk. Blood 2010, 115: 3314    
Aladjidi N, Leverger G, Leblanc T, Picat MQ, Michel G, Bertrand Y, Bader-Meunier B, Robert A, Nelken B, Gandemer V, Savel H, Stephan JL, Fouyssac F, Jeanpetit J, Thomas C, Rohrlich P, Baruchel A, Fischer A, Chêne G, Perel Y, Centre de Référence National des Cytopénies Auto-immunes de l'Enfant (CEREVANCE) New insights into childhood autoimmune hemolytic anemia: a French national observational study of 265 children. Haematologica 2011, 96: 655    
Albright AL, Packer RJ, Zimmerman R, Rorke LB, Boyett J, Hammond GD Magnetic resonance scans should replace biopsies for the diagnosis of diffuse brain stem gliomas: a report from the Children's Cancer Group. Neurosurgery 1993, 33: 1026    
Albrecht S, von Schweinitz D, Waha A, Kraus J, von Deimling A, Pietsch T Loss of maternal alleles on chromosome arm 11p in hepatoblastoma. Cancer Res 1994, 54: 5041    
Albrecht S, Hartmann W, Houshdaran F, Koch A, Gartner B, Prawitt D, Zabel BU, Russo P, Von Schweinitz D, Pietsch T Allelic loss but absence of mutations in the polyspecific transporter gene BWR1A on 11p15. 5 in hepatoblastoma. International journal of cancer. Journal international du cancer 2004, 111: 627    
Albert MH, Bittner TC, Nonoyama S, Notarangelo LD, Burns S, Imai K, Espanol T, Fasth A, Pellier I, Strauss G, Morio T, Gathmann B, Noordzij JG, Fillat C, Hoenig M, Nathrath M, Meindl A, Pagel P, Wintergerst U, Fischer A, Thrasher AJ, Belohradsky BH, Ochs HD X-linked thrombocytopenia (XLT) due to WAS mutations: clinical characteristics, long-term outcome, and treatment options. Blood 2010, 115: 3231    
Albert MH, Notarangelo LD, Ochs HD Clinical spectrum, pathophysiology and treatment of the Wiskott-Aldrich syndrome. Current opinion in hematology 2011, 18: 42    
Albert MH, Freeman AF Wiskott-Aldrich Syndrome (WAS) and Dedicator of Cytokinesis 8- (DOCK8) Deficiency. Frontiers in pediatrics 2019, 7: 451    
Albert MH, Slatter MA, Gennery AR, Güngör T, Bakunina K, Markovitch B, Hazelaar S, Sirait T, Courteille V, Aiuti A, Aleinikova OV, Balashov D, Bernardo ME, Bodova I, Bruno B, Cavazzana M, Chiesa R, Fischer A, Hauck F, Ifversen M, Kałwak K, Klein C, Kulagin A, Kupesiz A, Kuskonmaz B, Lindemans CA, Locatelli F, Lum SH, Maschan A, Meisel R, Moshous D, Porta F, Sauer MG, Sedlacek P, Schulz A, Suarez F, Vallée TC, Winiarski JH, Zecca M, Neven B, Veys P, Lankester AC Hematopoietic stem cell transplantation for Wiskott-Aldrich syndrome: an EBMT Inborn Errors Working Party analysis. Blood 2022, 139: 2066    
Allen JC, Helson L High-dose cyclophosphamide chemotherapy for recurrent CNS tumors in children. Journal of neurosurgery 1981, 55: 749    
Allen JC, Donahue B, DaRosso R, Nirenberg A Hyperfractionated craniospinal radiotherapy and adjuvant chemotherapy for children with newly diagnosed medulloblastoma and other primitive neuroectodermal tumors. International journal of radiation oncology, biology, physics 1996, 36: 1155    
Alter BP Cancer in Fanconi anemia, 1927-2001. Cancer 2003, 97: 425    
Althaus K, Najm J, Greinacher A MYH9 Related Platelet Disorders - Often Unknown and Misdiagnosed. Klinische Padiatrie 2011, 223, 120    
Alter BP Fanconi anemia and the development of leukemia. Best practice & research. Clinical haematology 2014, 27(3-4): 214    
Alten J, Klapper W, Leuschner I, Eckert C, Beier R, Vallo E, Krause M, Claviez A, Vieth S, Bleckmann K, Möricke A, Schrappe M, Cario G Secondary histiocytic sarcoma may cause apparent persistence or recurrence of minimal residual disease in childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 2015, 62: 1656    
Altintas B, Giri N, McReynolds LJ, Best A, Alter BP Genotype-phenotype and outcome associations in patients with Fanconi anemia: The National Cancer Institute cohort. Haematologica 2022,    
Alvarez O, Rodriguez MM, Jordan L, Sarnaik S Renal medullary carcinoma and sickle cell trait: A systematic review. Pediatric blood & cancer 2015, 62: 1694    
Ambros I, Attarbaschi A, Rumpler S, Luegmayr A, Turkof E, Gadner H, Ambros P Neuroblastoma cells provoke Schwann cell proliferation in vitro. Med Pediatr Oncol 2001, 36: 163    
Ambros P, Ambros I Pathology and biology guidelines for resectable and unresectable neuroblastic tumors and bone marrow examination guidelines. Med Pediatr Oncol 2001, 37: 492    
Ambros P, Ambros I, Kerbl R, Luegmayr A, Rumpler S, Ladenstein R, Amann G, Kovar H, Horcher E, De Bernardi B, Michon J, Gadner H Intratumoural heterogeneity of 1p deletions and MYCN amplification in neuroblastomas. Med Pediatr Oncol 2001, 36: 1    
American Psychiatric Association Statistical Manual for Mental Disorders. 2002 4th edition,    
Andrassy RJ, Chwals WJ Nutritional support of the pediatric oncology patient. Nutrition 1998, 14: 124    
Anderer G, Schrappe M, Brechlin A, Lauten M, Muti P, Welte K, Stanulla M Polymorphisms within glutathione S-transferase genes and initial response to glucocorticoids in childhood acute lymphoblastic leukaemia. Pharmacogenetics 2000, 10: 715    
Anderson FS, Kunin-Batson AS Neurocognitive late effects of chemotherapy in children: the past 10 years of research on brain structure and function. Pediatric blood & cancer 2009, 52: 159    
Andreiuolo F, Le Teuff G, Bayar MA, Kilday JP, Pietsch T, von Bueren AO, Witt H, Korshunov A, Modena P, Pfister SM, Pagès M, Castel D, Giangaspero F, Chimelli L, Varlet P, Rutkowski S, Frappaz D, Massimino M, Grundy R, Grill J, SIOP Ependymoma Biology Working Group BIOMECA (BIOlogical Markers for Ependymomas in Children and Adolescents) Integrating Tenascin-C protein expression and 1q25 copy number status in pediatric intracranial ependymoma prognostication: A new model for risk stratification. PloS one 2017, 12:e0178351    
Andres O, Henning K, Strauß G, Pflug A, Manukjan G, Schulze H Diagnosis of platelet function disorders: A standardized, rational, and modular flow cytometric approach. Platelets 2018, 29: 347    
Andreou D, Ranft A, Gosheger G, Timmermann B, Ladenstein R, Hartmann W, Bauer S, Baumhoer D, van den Berg H, Dijkstra PDS, Dürr HR, Gelderblom H, Hardes J, Hjorth L, Kreyer J, Kruseova J, Leithner A, Scobioala S, Streitbürger A, Tunn PU, Wardelmann E, Windhager R, Jürgens H, Dirksen U, GPOH-Euro-EWING99 consortium Which Factors Are Associated with Local Control and Survival of Patients with Localized Pelvic Ewing's Sarcoma? A Retrospective Analysis of Data from the Euro-EWING99 Trial. Clinical orthopaedics and related research 2020, 478: 290    
DeAngelis LM, Tong WP, Lin S, Fleisher M, Bertino JR Carboxypeptidase G2 rescue after high-dose methotrexate. J Clin Oncol 1996, 14: 2145    
Angastiniotis M, Lobitz S Thalassemias: An Overview. International journal of neonatal screening 2019, 5: 16    
Anteby I, Ramu N, Gradstein L, Miskin H, Pe'er J, Benezra D Ocular and orbital complications following the treatment of retinoblastoma. European journal of ophthalmology 1998, 8: 106    
Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, Bloomfield CD, Cazzola M, Vardiman JW The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 2016 May 19; 127: 2391    
Ardon H, De Vleeschouwer S, Van Calenbergh F, Claes L, Kramm CM, Rutkowski S, Wolff JE, Van Gool SW Adjuvant dendritic cell-based tumour vaccination for children with malignant brain tumours. Pediatric blood & cancer 2010, 54: 519    
Arico M, Valsecchi M, Camitta B, Schrappe M, Chessells J, Baruchel A, Gaynon P, Silverman L, Janka-Schaub G, Kamps W, Pui C, Masera G Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia. N Engl J Med 2000, 342: 998    
Arlt B, Zasada C, Baum K, Wuenschel J, Mastrobuoni G, Lodrini M, Astrahantseff K, Winkler A, Schulte JH, Finkler S, Forbes M, Hundsdoerfer P, Guergen D, Hoffmann J, Wolf J, Eggert A, Kempa S, Deubzer HE Inhibiting phosphoglycerate dehydrogenase counteracts chemotherapeutic efficacy against MYCN-amplified neuroblastoma. International journal of cancer 2021, 148: 1219    
Armenian SH, Sun CL, Kawashima T, Arora M, Leisenring W, Sklar CA, Baker KS, Francisco L, Teh JB, Mills G, Wong FL, Rosenthal J, Diller LR, Hudson MM, Oeffinger KC, Forman SJ, Robison LL, Bhatia S Long-term health-related outcomes in survivors of childhood cancer treated with HSCT versus conventional therapy: a report from the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS). Blood 2011 Aug 4; 118: 1413    
Arnhold V, Schmelz K, Proba J, Winkler A, Wünschel J, Toedling J, Deubzer HE, Künkele A, Eggert A, Schulte JH, Hundsdoerfer P Reactivating TP53 signaling by the novel MDM2 inhibitor DS-3032b as a therapeutic option for high-risk neuroblastoma. Oncotarget 2018 Jan 5; 9: 2304    
Arzneimittelkommission der deutschen Ärzteschaft Neue Arzneimittel. 2018 online publiziert aufgerufen am 1.12.2021    
Asmar L, Gehan E, Newton W, Webber B, Marsden H, van Unnik A, Hamoudi A, Shimada H, Tsokos M, Harms D Agreement among and within groups of pathologists in the classification of rhabdomyosarcoma and related childhood sarcomas. Report of an international study of four pathology classifications. Cancer 1994, 74: 2579    
Attarbaschi A, Mann G, Dworzak M, Trebo M, Muhlegger N, Reiter A, Horcher E, Gadner H The role of surgery in the treatment of pediatric B-cell non-Hodgkin's lymphoma. J Pediatr Surg 2002, 37: 1470    
Attarbaschi A, Mann G, Dworzak M, Trebo M, Urban C, Fink F, Horcher E, Reiter A, Riehm H, Gadner H Malignant non-Hodgkin's lymphoma of childhood and adolescence in Austria--therapy results between 1986 and 2000. Wien Klin Wochenschr 2002, 114: 978    
Attarbaschi A, Mann G, Dworzak M, Wiesbauer P, Schrappe M, Gadner H Mediastinal mass in childhood T-cell acute lymphoblastic leukemia. Med Pediatr Oncol 2002, 39: 558    
Attarbaschi A, Dworzak M, Steiner M, Urban C, Fink F, Reiter A, Gadner H, Mann G Outcome of children with primary resistant or relapsed non-Hodgkin lymphoma and mature B-cell leukemia after intensive first-line treatment: a population-based analysis of the Austrian Cooperative Study Group. Pediatr Blood Cancer 2005, 44: 70    
Attiyeh EF, London WB, Mossé YP, Wang Q, Winter C, Khazi D, McGrady PW, Seeger RC, Look AT, Shimada H, Brodeur GM, Cohn SL, Matthay KK, Maris JM, Children's Oncology Group Chromosome 1p and 11q deletions and outcome in neuroblastoma. The New England journal of medicine 2005 Nov 24; 353: 2243    
Attarbaschi A, Mann G, Panzer-Grümayer R, Röttgers S, Steiner M, König M, Csinady E, Dworzak MN, Seidel M, Janousek D, Möricke A, Reichelt C, Harbott J, Schrappe M, Gadner H, Haas OA Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Münster (ALL-BFM) trials. Journal of clinical oncology 2008, 26: 3046    
Attarbaschi A, Panzer-Grümayer R, Mann G, Möricke A, König M, Mecklenbräuker A, Teigler-Schlegel A, Bradtke J, Harbott J, Göhring G, Stanulla M, Schrappe M, Zimmermann M, Haas OA, Austrian and German ALL-BFM (Berlin-Frankfurt-Münster) Study Group Minimal residual disease-based treatment is adequate for relapse-prone childhood acute lymphoblastic leukemia with an intrachromosomal amplification of chromosome 21: the experience of the ALL-BFM 2000 trial. Klinische Padiatrie 2014, 226(6-7): 338    
Attarbaschi A, Carraro E, Abla O, Barzilai-Birenboim S, Bomken S, Brugieres L, Bubanska E, Burkhardt B, Chiang AK, Csoka M, Fedorova A, Jazbec J, Kabickova E, Krenova Z, Lazic J, Loeffen J, Mann G, Niggli F, Miakova N, Osumi T, Ronceray L, Uyttebroeck A, Williams D, Woessmann W, Wrobel G, Pillon M, European Intergroup for Childhood Non-Hodgkin Lymphoma (EICNHL) and the International Berlin-Frankfurt-Münster (i-BFM) Study Group Non-Hodgkin lymphoma and pre-existing conditions: spectrum, clinical characteristics and outcome in 213 children and adolescents. Haematologica 2016, 101: 1581    
Attarbaschi A, Mann G, Zimmermann M, Bader P, Barisone E, Basso G, Biondi A, Cario G, Cazzaniga G, Colombini A, Flotho C, Kuhlen M, Lang P, Lauten M, Linderkamp C, Locatelli F, Lo Nigro L, Moericke A, Niggli F, Panzer-Gruemayer R, Parasole R, Peters C, Caterina Putti M, Rizzari C, Suttorp M, Valsecchi MG, Conter V, Schrappe M, on behalf of the AIEOP-BFM (Associazione Italiana di Ematologia e Oncologia Pediatrica & Berlin-Frankfurt-Muenster) Study Group Randomized post-induction and delayed intensification therapy in high-risk pediatric acute lymphoblastic leukemia: long-term results of the international AIEOP-BFM ALL 2000 trial. Leukemia 2019 Dec 5;    
Attarbaschi A, Möricke A, Harrison CJ, Mann G, Baruchel A, De Moerloose B, Conter V, Devidas M, Elitzur S, Escherich G, Hunger SP, Horibe K, Manabe A, Loh ML, Pieters R, Schmiegelow K, Silverman LB, Stary J, Vora A, Pui CH, Schrappe M, Zimmermann M, Ponte-di-Legno Childhood Acute Lymphoblastic Leukemia Working Group Outcomes of Childhood Noninfant Acute Lymphoblastic Leukemia With 11q23/KMT2A Rearrangements in a Modern Therapy Era: A Retrospective International Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2023, 41: 1404    
Attiyeh EF, London WB, Mossé YP, Wang Q, Winter C, Khazi D, McGrady PW, Seeger RC, Look AT, Shimada H, Brodeur GM, Cohn SL, Matthay KK, Maris JM, Children's Oncology Group Chromosome 1p and 11q deletions and outcome in neuroblastoma. The New England journal of medicine 2005 Nov 24; 353: 2243    
Auerbach AD Fanconi anemia and its diagnosis. Mutat Res 2009, 668(1-2): 4    
Au-Yeung RKH, Richter J, Iaccarino I, Abramov D, Bacon CM, Balagué O, d'Amore ESG, Simonitsch-Klupp I, Hebeda K, Nakazawa A, Oschlies I, Kontny U, Woessmann W, Burkhardt B, Klapper W Molecular features of non-anaplastic peripheral T-cell lymphoma in children and adolescents. Pediatric blood & cancer 2021, 68:e29285    
Au-Yeung RKH, Richter J, Iaccarino I, Abramov D, Bacon CM, Balagué O, d'Amore ESG, Simonitsch-Klupp I, Hebeda K, Nakazawa A, Oschlies I, Kontny U, Woessmann W, Burkhardt B, Klapper W Molecular features of non-anaplastic peripheral T-cell lymphoma in children and adolescents. Pediatric blood & cancer 2021, 68:e29285    
Au-Yeung RKH, Padilla LA, Zimmermann M, Reinke S, Oschlies I, Escherich G, Woessmann W, Burkhardt B, Klapper W Frequency and prognostic implications of KMT2A rearrangements in children with precursor B-cell lymphoma. Leukemia 2023, 37: 488    
Au-Yeung RKH, Padilla LA, Zimmermann M, Reinke S, Oschlies I, Escherich G, Woessmann W, Burkhardt B, Klapper W Frequency and prognostic implications of KMT2A rearrangements in children with precursor B-cell lymphoma. Leukemia 2023, 37: 488    
71 items found

The literature database is sorted by the first author's last name - please choose from the alphabet. It comprises the references that were reported by the trial co-ordinating centres and those which are referenced in this information service, for example by the patient information texts.